Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eucerin is a leading global dermocosmetic brand owned by Beiersdorf, specializing in science-based skincare solutions developed in collaboration with dermatologists. The company's portfolio focuses on addressing specific skin conditions such as hyperpigmentation, aging, acne, and atopic dermatitis through clinically proven active ingredients. Key innovations include the development of Thiamidol for reducing dark spots and the use of Urea for dry skin treatment. Eucerin products are widely recommended by medical professionals and are distributed through pharmacies and healthcare retailers worldwide. The brand emphasizes high skin tolerability and efficacy, supported by extensive clinical trials and dermatological research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eucerin.